Article Information
History
- December 2, 2020.
Article Versions
- Version 1 (December 15, 2019 - 02:39).
- Version 2 (March 27, 2020 - 11:12).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Peter Georgeson1,2,
- Bernard J. Pope1,2,3,
- Christophe Rosty1,2,4,5,
- Mark Clendenning1,2,
- Khalid Mahmood1,2,3,
- Jihoon E. Joo1,2,
- Romy Walker1,2,
- Ryan Hutchinson1,2,
- Susan Preston1,2,
- Julia Como1,2,
- Sharelle Joseland1,2,
- Aung K. Win6,8,
- Finlay A. Macrae6,7,
- John L. Hopper8,
- Dmitry Mouradov9,10,
- Peter Gibbs9,10,11,
- Oliver M. Sieber9,10,12,13,
- Dylan E. O’Sullivan14,15,
- Darren R. Brenner14,15,16,
- Steve Gallinger17,18,19,
- Mark A. Jenkins2,8,
- Ingrid M. Winship6,20 and
- Daniel D. Buchanan1,2,6,*
- 1Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia
- 2University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia
- 3Melbourne Bioinformatics, The University of Melbourne, Carlton, Victoria, Australia
- 4Envoi Pathology, Brisbane, Queensland, Australia
- 5University of Queensland, School of Medicine, Herston, Queensland, Australia
- 6Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 7Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Parkville, Victoria, Australia
- 8Centre for Epidemiology and Biostatistics, The University of Melbourne, Carlton, Victoria, Australia
- 9Personalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville, Victoria, Australia
- 10Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia
- 11Department of Medical Oncology, Western Health, Victoria, Australia
- 12Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia
- 13Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
- 14Department of Oncology, University of Calgary, Calgary, Canada
- 15Department of Community Health Sciences, University of Calgary, Calgary, Canada
- 16Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Canada
- 17Ontario Institute for Cancer Research, Toronto, Ontario, Canada
- 18Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
- 19Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
- 20Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia
- ↵*Correspondence:
Associate Professor Daniel Buchanan, Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Victorian Comprehensive Cancer Centre, 305 Grattan Street, Parkville, Victoria, 3010 Australia, Ph: +61 385597004, Email: daniel.buchanan{at}unimelb.edu.au
Posted December 02, 2020.
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos